Isolated Severe Immune Thrombocytopenia due to Acute Brucellosis

  • Ozlem Guzel TunccanEmail author
  • Murat Dizbay
  • Esin Senol
  • Zeynep Aki
  • Kevser Ozdemir
Case Report


Mild anemia and leukopenia are the most common hematologic findings in the course of acute brucellosis. However severe form of thrombocytopenia is less frequently reported. The patient was admitted to the hospital with fever, gingival bleeding, and petechial skin lesions related to severe thrombocytopenia. He was investigated for the causes of thrombocytopenia. Test results showed that Wright agglutination test was positive at 1/5120 titer, and blood culture was positive for Brucella melitensis. Finally, he was diagnosed as acute brucellosis. Rifampicin and doxycycline treatment was started on he third day of admission. A bone marrow aspiration was performed on the seventh day of admission because of severe thrombocytopenia did not response to brucellosis treatment. The result of bone marrow aspiration was consistent with idiopathic thrombocytopenic purpura. With the addition of corticosteroid treatment, his complaints resolved immediately, and thrombocyte count rose to normal range. He was discharged on the 12th day of rifampicin and doxycycline therapy, and he was successfully completed 6-week therapy. In cases of brucella induced immune thrombocytopenia, corticosteroid treatment might be useful for the prevention of bleeding complications.


Brucellosis Immune thrombocytopenia Corticosteroid treatment 


  1. 1.
    Buzgan T, Karahocagil MK, Irmak H, Baran AI, Karsen H, Evirgen O, Akdeniz H (2010) Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis 14(6):e469–e478PubMedCrossRefGoogle Scholar
  2. 2.
    Sari I, Altuntas F, Hacioglu S, Kocyigit I, Sevinc A, Sacar S, Deniz K, Alp E, Eser B, Yildiz O, Kaynar L, Unal A, Cetin MA (2008) Multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis. Am J Hematol 83(4):334–339PubMedCrossRefGoogle Scholar
  3. 3.
    Akdeniz H, Irmak H, Seçkinli T, Buzgan T, Demiröz AP (1998) Hematological manifestations in brucellosis cases in Turkey. Acta Med Okayama 52(1):63–65PubMedGoogle Scholar
  4. 4.
    Madkour MM (2001) Haematological localisation. In: Madkour MM (ed) Madkour’s Brucellosis. Springer, Germany, pp 33–38CrossRefGoogle Scholar
  5. 5.
    Pappas G, Kitsanou M, Christou L, Tsianos E (2004) Immune thrombocytopenia attributed to brucellosis and other mechanisms of Brucella-induced thrombocytopenia. Am J Hematol 5(3):139–141CrossRefGoogle Scholar
  6. 6.
    Yilmaz M, Tiryaki O, Namiduru M, Okan V, Oguz A, Buyukhatipoglu H, Karaoglan I, Yilmaz B (2007) Brucellosis-induced immune thrombocytopenia mimicking ITP: a report of seven cases. Int J Lab Hematol 29(6):442–445PubMedCrossRefGoogle Scholar
  7. 7.
    Young EJ, Tarry A, Genta RM, Ayden N, Gotuzzo E (2000) Thrombocytopenic purpura associated with brucellosis: report of 2 cases and literature review. Clin Infect Dis 31(4):904–909PubMedCrossRefGoogle Scholar
  8. 8.
    Akbayram S, Dogan M, Akgun C, Peker E, Parlak M, Oner AF (2011) Disseminated intravascular coagulation in a case of Brucellosis. Clin Appl Thromb Hemost 17(6):E10–E12PubMedCrossRefGoogle Scholar
  9. 9.
    Erduran E, Makuloglu M, Mutlu M (2010) A rare hematological manifestation of brucellosis: reactive hemophagocytic syndrome. J Microbiol Immunol Infect 43(2):159–162PubMedCrossRefGoogle Scholar
  10. 10.
    Sari I, Kocyigit I, Altuntas F, Kaynar L, Eser B (2008) An unusual case of acute brucellosis presenting with Coombs-positive autoimmune hemolytic anemia. Intern Med 47(11):1043–1045PubMedCrossRefGoogle Scholar
  11. 11.
    Altuntas F, Yildiz O, Sari I, Eser B, Cetin M, Unal A (2005) Intravenous gamma globulin is effective as an urgent treatment in Brucella-induced severe thrombocytopenic purpura. Am J Hematol 80(3):204–206PubMedCrossRefGoogle Scholar
  12. 12.
    Gürsoy B, Tekin-Koruk S, Sırmatel F, Karaağaç L (2008) Brucellosis. An evaluation of 140 cases. Klimik Derg 21(3):101–104Google Scholar
  13. 13.
    Colmenero JD, Reguera JM, Martos F, Sánchez-De-Mora D, Delgado M, Causse M, Martín-Farfán A, Juárez C (1996) Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 75(4):195–211CrossRefGoogle Scholar
  14. 14.
    Mantur BG, Amarnath SK, Shinde RS (2007) Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol 25(3):188–202PubMedCrossRefGoogle Scholar
  15. 15.
    Sevinc A, Kutlu NO, Kuku I, Ozgen U, Aydogdu I, Soylu H (2000) Severe epistaxis in brucellosis-induced isolated thrombocytopenia: a report of two cases. Clin Lab Haematol 22(6):373–375PubMedCrossRefGoogle Scholar

Copyright information

© Indian Society of Haematology & Transfusion Medicine 2013

Authors and Affiliations

  • Ozlem Guzel Tunccan
    • 1
    Email author
  • Murat Dizbay
    • 1
  • Esin Senol
    • 1
  • Zeynep Aki
    • 2
  • Kevser Ozdemir
    • 1
  1. 1.Department of Clinical Microbiology and Infectious Diseases, Faculty of MedicineGazi UniversityAnkaraTurkey
  2. 2.Department of Hematology, Faculty of MedicineGazi UniversityAnkaraTurkey

Personalised recommendations